Skip to main content

Advertisement

SpringerLink
Log in

AAIC 2023

New CRISPR-based strategies for Alzheimer disease

  • Research Highlight
  • Published:

From Nature Reviews Neurology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

Original articles

  • Aulston, B. D. et al. In vivo safety and efficacy of a CRISPR-based gene therapy for Alzheimer’s disease. AAIC abstr. 76735 (2023)

  • Kantor, B. et al. APOE-targeted epigenome therapy for late onset Alzheimer’s disease. AAIC abstr. 80698 (2023)

Download references

Author information

Authors and Affiliations

  1. Nature Reviews Neurology http://www.nature.com/nrneurol/

    Lisa Kiani

Authors
  1. Lisa Kiani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lisa Kiani.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kiani, L. New CRISPR-based strategies for Alzheimer disease. Nat Rev Neurol 19, 507 (2023). https://doi.org/10.1038/s41582-023-00856-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41582-023-00856-5

  • Springer Nature Limited

Search

Navigation